Literature DB >> 31042400

A simple method to monitor hepatic gluconeogenesis and triglyceride synthesis following oral sugar tolerance test in obese adolescents.

Anne-Marie Carreau1, Eunsook S Jin2, Yesenia Garcia-Reyes1, Haseeb Rahat1, Kristen J Nadeau1,3, Craig R Malloy2, Melanie Cree-Green1,3.   

Abstract

Hepatic energy metabolism is a key element in many metabolic diseases. Hepatic anaplerosis provides carbons for gluconeogenesis (GNG) and triglyceride (TG) synthesis. We aimed to optimize a protocol that measures hepatic anaplerotic contribution for GNG, TG synthesis, and hepatic pentose phosphate pathway (PPP) activity using a single dose of oral [U-13C3]glycerol paired with an oral sugar tolerance test (OSTT) in a population with significant insulin resistance. The OSTT (75 g glucose + 25 g fructose) was administered to eight obese adolescents with polycystic ovarian syndrome (PCOS) followed by ingestion of [U-13C3]glycerol at t = 180 or t = 210 min. 13C-labeling patterns of serum glucose and TG-glycerol were determined by nuclear magnetic resonance. 13C enrichment in plasma TG-glycerol was detectable and stable from 240 to 390 min with the [U-13C3]glycerol drink at t = 180 min(3.65 ± 2.3 to 4.47 ± 1.4%; P > 0.4), but the enrichment was undetectable at 240 min with the glycerol drink at t = 210 min. The relative contribution from anaplerosis was determined at the end of the OSTT [18.5 ±3.4% (t = 180 min) vs. 16.0 ± 3.5% (t = 210 min); P = 0.27]. [U-13C3]glycerol was incorporated into GNG 390 min after the OSTT with an enrichment of 7.5-12.5%. Glucose derived from TCA cycle activity was 0.3-1%, and the PPP activity was 2.8-4.7%. In conclusion, it is possible to obtain relative measurements of hepatic anaplerotic contribution to both GNG and TG esterification following an OSTT in a highly insulin-resistant population using a minimally invasive technique. Tracer administration should be timed to allow enough de novo TG esterification and endogenous glucose release after the sugar drink.

Entities:  

Keywords:  anaplerosis; gluconeogenesis; insulin resistance; liver metabolism; mitochondria; pentose phosphate pathway; polycystic ovarian syndrome

Mesh:

Substances:

Year:  2019        PMID: 31042400      PMCID: PMC6692761          DOI: 10.1152/ajpregu.00047.2019

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  25 in total

1.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

Authors:  M Roden; H Stingl; V Chandramouli; W C Schumann; A Hofer; B R Landau; P Nowotny; W Waldhäusl; G I Shulman
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

2.  Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.

Authors:  Nishanth E Sunny; Elizabeth J Parks; Jeffrey D Browning; Shawn C Burgess
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

3.  Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose.

Authors:  Eunsook S Jin; Shawn C Burgess; Matthew E Merritt; A Dean Sherry; Craig R Malloy
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-11-23       Impact factor: 4.310

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction.

Authors:  Jeffrey D Browning; Brian Weis; Jeannie Davis; Santhosh Satapati; Matthew Merritt; Craig R Malloy; Shawn C Burgess
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 6.  Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.

Authors:  Chrysi Koliaki; Michael Roden
Journal:  Mol Cell Endocrinol       Date:  2013-06-12       Impact factor: 4.102

7.  Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative.

Authors:  Eunsook S Jin; John G Jones; Matthew Merritt; Shawn C Burgess; Craig R Malloy; A Dean Sherry
Journal:  Anal Biochem       Date:  2004-04-15       Impact factor: 3.365

8.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

9.  Influence of liver triglycerides on suppression of glucose production by insulin in men.

Authors:  Eunsook S Jin; Magdalene Szuszkiewicz-Garcia; Jeffrey D Browning; Jeannie D Baxter; Nicola Abate; Craig R Malloy
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

10.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

View more
  4 in total

1.  Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling.

Authors:  Cecilia Diniz Behn; Eunsook S Jin; Kate Bubar; Craig Malloy; Elizabeth J Parks; Melanie Cree-Green
Journal:  J Investig Med       Date:  2019-09-24       Impact factor: 2.895

2.  11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome.

Authors:  Anya E Taylor; Meredith A Ware; Emily Breslow; Laura Pyle; Cameron Severn; Kristen J Nadeau; Christine L Chan; Megan M Kelsey; Melanie Cree-Green
Journal:  J Endocr Soc       Date:  2022-03-09

3.  Cross-talk between ANGPTL4 gene SNP Rs1044250 and weight management is a risk factor of metabolic syndrome.

Authors:  Zhoujie Tong; Jie Peng; Hongtao Lan; Wenwen Sai; Yulin Li; Jiaying Xie; Yanmin Tan; Wei Zhang; Ming Zhong; Zhihao Wang
Journal:  J Transl Med       Date:  2021-02-16       Impact factor: 5.531

4.  Divergent effects of glutathione depletion on isocitrate dehydrogenase 1 and the pentose phosphate pathway in hamster liver.

Authors:  Eunsook S Jin; Min H Lee; Craig R Malloy
Journal:  Physiol Rep       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.